EUObserver reports that the European Medicines Agency has reversed its long-held stance on releasing studies on drug side effects after pressure from the European Ombudsman. The London-based agency, which evaluates drugs in the EU, on Wednesday (11 August) said that it would issue data on anti-acne medication Roaccutane produced by pharma giant Roche in the coming weeks.
Read more here: http://euobserver.com/9/30613/?rk=1
ICRM Opens Call for Nominations for 2026 Board of Regents
-
The Institute for Certified Records Managers (ICRM) has announced it is
seeking nominations to serve on the ICRM Board of Regents. Active CRMs (not
CRAs)...
2 days ago
No comments:
Post a Comment